FierceBiotech Jun 5, 2026 Affibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejection
FierceBiotech Jun 5, 2026 Insulet debuts latest enhancements to popular Omnipod insulin delivery system
FierceBiotech Jun 5, 2026 How RA Capital is offering its biotechs ‘Chinese clinical expertise in a box’
FierceBiotech Jun 5, 2026 At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
FierceBiotech Jun 4, 2026 Autobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2
FierceBiotech Jun 4, 2026 As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
FierceBiotech Jun 4, 2026 Innovent, fresh from $1.2B deal, posts phase 3 win for Takeda-partnered ADC
FierceBiotech Jun 4, 2026 From business strategy to CAR-T responses, for Cabaletta it’s all about ‘durability’
FierceBiotech Jun 4, 2026 Alnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneer
FierceBiotech Jun 3, 2026 Lilly, Boehringer to slash at least $1B each from planned investments in Germany
FierceBiotech Jun 3, 2026 As Akeso takes center stage at ASCO, China biotech industry cements its coming of age